These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Purification of herpes simplex virus glycoproteins B and C using monoclonal antibodies and their ability to protect mice against lethal challenge. Roberts PL, Duncan BE, Raybould TJ, Watson DH. J Gen Virol; 1985 May; 66 ( Pt 5)():1073-85. PubMed ID: 2582080 [Abstract] [Full Text] [Related]
4. Stable erythrocyte diagnostic preparation for passive haemagglutination test with herpes simplex virus antigen. Krichevskaya GI, Basova NN. Acta Virol; 1976 Oct; 20(5):418-23. PubMed ID: 11670 [Abstract] [Full Text] [Related]
6. Glutaraldehyde stabilisation of antibody-linked erythrocytes for use in reverse passive and related haemagglutination assays. Cranage MP, Gurner BW, Coombs RR. J Immunol Methods; 1983 Nov 11; 64(1-2):7-16. PubMed ID: 6315824 [Abstract] [Full Text] [Related]
8. Monoclonal antibodies directed against a 130K glycoprotein of bovine herpesvirus 2 cross-react with glycoprotein B of herpes simplex virus. Conraths FJ, Pauli G, Ludwig H. Virus Res; 1988 Apr 11; 10(1):53-63. PubMed ID: 2837013 [Abstract] [Full Text] [Related]
14. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis. Ritchie MH, Oakes JE, Lausch RN. Invest Ophthalmol Vis Sci; 1993 Jul 11; 34(8):2460-8. PubMed ID: 8392037 [Abstract] [Full Text] [Related]
15. Characterization of monoclonal antibodies reactive to several biochemically distinct human cytomegalovirus glycoprotein complexes. Kari B, Lussenhop N, Goertz R, Wabuke-Bunoti M, Radeke R, Gehrz R. J Virol; 1986 Nov 11; 60(2):345-52. PubMed ID: 3021969 [Abstract] [Full Text] [Related]
18. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants. Bishop GA, Marlin SD, Schwartz SA, Glorioso JC. J Immunol; 1984 Oct 11; 133(4):2206-14. PubMed ID: 6206157 [Abstract] [Full Text] [Related]
19. Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease. Dix RD, Pereira L, Baringer JR. Infect Immun; 1981 Oct 11; 34(1):192-9. PubMed ID: 6271681 [Abstract] [Full Text] [Related]
20. Passive immune protection by herpes simplex virus-specific monoclonal antibodies and monoclonal antibody-resistant mutants altered in pathogenicity. Kümel G, Kaerner HC, Levine M, Schröder CH, Glorioso JC. J Virol; 1985 Dec 11; 56(3):930-7. PubMed ID: 2415719 [Abstract] [Full Text] [Related] Page: [Next] [New Search]